Clinical Trial Update: A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing BioChaperone Combo with Humalog Mix25 and with simultaneous Humalog and Lantus injections in Type 2 diabetes; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BioChaperone Combo
• Humalog (insulin lispro)
• Humalog Mix25 (insulin lispro protamine suspension)
• Lantus (insulin glargine)

Snippet

Sponsor: Adocia | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED